Latest On Lexicon Pharmaceuticals, Inc (LXRX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-27 03:40 EST | News | Lexicon's sotagliflozin wins FDA nod for heart failure; up 11% after hours | N/A |  |
| 2023-05-20 02:16 EST | News | Lexicon Pharmaceuticals: May 27 PDUFA Date For Heart Failure Drug Looks Crucial | N/A | |
| 2023-05-03 00:17 EST | News | Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.02M misses by $0.01M | N/A | |
| 2023-05-03 00:17 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-03-07 21:33 EST | News | Lexicon initiated at buy at Jefferies on uptake of heart failure candidate sotagliflozin | N/A | |
| 2023-03-05 05:48 EST | News | Lexicon Pharma: Advancing A Worthwhile Pipeline But Commercialization Remains A Key Risk | N/A | |
| 2023-03-03 23:40 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-02 18:47 EST | News | Lexicon Pharmaceuticals GAAP EPS of -$0.16 misses by $0.03, revenue of $0.03M misses by $0.02M | N/A | |
| 2022-12-25 09:39 EST | News | Nothing Ever Comes Easy For Lexicon, But Maybe Sotagliflozin Will Prevail In Heart Failure | N/A | |
| 2022-12-22 00:30 EST | News | Lexicon Pharmaceuticals down 11% after neuralgia candidate misses phase 2 primary endpoint | N/A | |
| 2022-12-09 03:48 EST | News | Lexicon Continues To Drift Ahead Of An Expected FDA Approval And A High-Risk Commercialization Effort | N/A | |
| 2022-11-10 02:31 EST | News | Lexicon Pharmaceuticals GAAP EPS of -$0.13 | N/A | |
| 2022-11-10 02:30 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-09 08:18 EST | News | Lexicon Pharmaceuticals Q3 Earnings Preview | N/A | |
| 2022-10-01 12:43 EST | News | Lexicon Pharma: Key Regulatory Event In May 2023 | N/A | |
| 2022-08-12 21:44 EST | News | Lexicon adds 15% as Piper Sandler sees “blockbuster potential” for key assets | N/A | |
| 2022-08-03 08:00 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-02 17:45 EST | News | Lexicon Pharmaceuticals GAAP EPS of -$0.16 in-line, revenue of $0.04M misses by $0.06M | N/A | |
| 2022-08-02 03:15 EST | News | Lexicon Pharmaceuticals Q2 Earnings Preview | N/A | |
| 2022-07-28 10:52 EST | News | Lexicon Pharma slumps on pricing $85M stock offering and concurrent private placement | N/A | |
| 2022-07-27 21:12 EST | News | Lexicon heart failure therapy undergoes FDA review again | N/A | |
| 2022-07-27 21:12 EST | News | Lexicon Pharmaceuticals stock slides on proposed stock offering | N/A | |
| 2022-07-13 18:14 EST | News | Lexicon Pharmaceuticals: Encouraging Signs Of Efficacy In Pain, But Still Looking For A Clear Win | N/A | |
| 2022-06-29 19:33 EST | News | Lexicon Pharmaceuticals up 9% on mid-stage study for diabetic neuropathy drug | N/A | |
| 2022-06-01 01:38 EST | News | Lexicon refiles for FDA approval of sotagliflozin to treat heart failure | N/A | |
| 2022-06-01 01:38 EST | News | Lexicon: Beaten Down Stock, High Risk-Reward Situation Ahead | N/A | |
| 2022-05-06 04:51 EST | News | Lexicon Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01, revenue of $0.04M misses by $0.01M | N/A | |
| 2022-05-06 04:51 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-05 05:47 EST | News | Lexicon Pharmaceuticals Q1 Earnings Preview | N/A | |
| 2022-03-19 00:37 EST | News | Lexicon Pharmaceuticals enters into $150M loan facility for potential sotagliflozin launch | N/A | |
| 2022-03-02 03:22 EST | News | Lexicon Stumbles With Sotagliflozin, But The Heart Failure Opportunity Is Getting More Interesting | N/A | |
| 2022-02-28 14:27 EST | News | Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.01M | N/A | |
| 2022-02-28 14:27 EST | News | Lexicon pulls U.S. marketing application for heart disease drug | N/A | |
| 2022-02-28 14:27 EST | News | Lexicon Pharmaceuticals, Inc.'s (LXRX) CEO Lonnel Coats On Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-01-13 17:36 EST | News | Lexicon Pharmaceuticals expects potential launch of heart drug in H2 | N/A | |
| 2021-11-15 08:13 EST | News | Lexicon highlights potential of diabetes drug in heart failure and blood glucose control | N/A | |
| 2021-11-04 12:10 EST | News | Lexicon Pharmaceuticals falls 8% despite Q3 earnings beat | N/A | |
| 2021-11-04 12:10 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-02 19:00 EST | News | Lexicon Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-08-30 15:10 EST | News | Lexicon Pharma welcomes recognition of SGLT inhibitors as SoC for heart failure patients | N/A | |
| 2021-08-23 11:24 EST | News | Lexicon’s sotagliflozin shows additional benefits in reducing cardiovascular endpoints | N/A | |
| 2021-08-06 06:19 EST | News | Lexicon Pharmaceuticals Still On The Launch Pad, With An Uncertain Trajectory | N/A | |
| 2021-07-30 17:03 EST | News | Lexicon Pharmaceuticals appoints Craig Granowitz as Chief Medical Officer | N/A | |
| 2021-07-30 17:03 EST | News | Lexicon Pharmaceuticals EPS beats by $0.03, beats on revenue | N/A | |
| 2021-07-21 15:05 EST | News | Lexicon Pharmaceuticals Still A Very High-Risk/High-Reward Biopharma Name | N/A | |
| 2021-05-07 11:23 EST | News | Lexicon Pharmaceuticals EPS beats by $0.02 | N/A | |
| 2021-05-07 11:23 EST | News | Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-03-17 03:31 EST | News | Lexicon Still Working Hard To Maximize The Value Of Sotagliflozin | N/A | |
| 2021-03-16 21:20 EST | Earnings Estimate | An EPS average of -$0.47 is estimated for the 2022 year. | Sell | |
| 2021-03-16 21:20 EST | Earnings Estimate | An EPS average of -$0.15 is estimated for the quarter ending on June 30, 2021. | Sell | |
About Lexicon Pharmaceuticals, Inc (LXRX):
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain; and LX2761. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
General
- Name Lexicon Pharmaceuticals, Inc
- Symbol LXRX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 78
- Last Split Factor1:7
- Last Split Date2015-05-21
- Fiscal Year EndDecember
- IPO Date2000-04-07
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.lexpharma.com
View More
Valuation
- Trailing PE 3.74
- Price/Sales (Trailing 12 Mt.) 24.56
- Price/Book (Most Recent Quarter) 11.79
- Enterprise Value Revenue 39.27
- Enterprise Value EBITDA 2.92
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.62
- Next Year EPS Estimate -$0.47
- Next Quarter EPS Estimate -$0.16
- Profit Margin -244%
- Operating Margin -722%
- Return on Assets -35%
- Return on Equity -43%
- Revenue 24 million
- Earnings Per Share $0.37
- Revenue Per Share $0.22
- Gross Profit -129055000
- Quarterly Earnings Growth -97.7%
View More
Highlights
- Market Capitalization 917.37 million
- EBITDA 82.53 million
- PE Ratio -3.09
- PEG Ratio -0.14
- Analyst Target Price $9
- Book Value Per Share $1.11
View More
Share Statistics
- Shares Outstanding 144.35 million
- Shares Float 55.35 million
- % Held by Insiders 90%
- % Held by Institutions 91.96%
- Shares Short 3.59 million
- Shares Short Prior Month 4.49 million
- Short Ratio 1.56
- Short % of Float 6%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 1.71
- 52 Week High $9.43
- 52 Week Low $1.03
- 50 Day Moving Average 7.65
- 200 Day Moving Average 3.78
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Lexicon Pharmaceuticals, Inc (LXRX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Lexicon Pharmaceuticals, Inc (LXRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-10 | $199000 | -$0.04 | -$0.29 | 86.21% |
| 2020-09-30 | 2020-10-29 | $6.63 million | $0.71 | $0.21 | 231.31% |
| 2020-06-30 | 2020-07-29 | $N/A | -$0.65 | -$0.61 | -5.98% |
| 2020-03-31 | 2020-04-27 | $8 million | -$0.63 | -$0.68 | 7.62% |
| 2019-12-31 | 2020-03-12 | $8.73 million | -$0.48 | -$0.77 | 37.72% |
| 2019-09-30 | 2019-11-07 | $294.45 million | $1.95 | $1.31 | 49.43% |
| 2019-06-30 | 2019-07-31 | $9.68 million | -$0.22 | -$0.06 | -289.38% |
| 2019-03-31 | 2019-05-01 | $9.22 million | -$0.21 | -$0.22 | 2.33% |
| 2018-12-31 | 2019-03-13 | $17.39 million | -$0.16 | -$0.28 | 42.28% |
| 2018-09-30 | 2018-11-01 | $6.86 million | -$0.26 | -$0.33 | 21.12% |
| 2018-06-30 | 2018-07-30 | $13.75 million | -$0.33 | -$0.35 | 6.36% |
| 2018-03-31 | 2018-05-03 | $25.21 million | -$0.40 | -$0.42 | 4.65% |
| 2017-12-31 | 2018-02-22 | $33.05 million | -$0.27 | -$0.41 | 34.64% |
| 2017-09-30 | 2017-11-08 | $26.94 million | -$0.29 | -$0.37 | 21.15% |
| 2017-06-30 | 2017-08-01 | $12.05 million | -$0.33 | -$0.44 | 24.95% |
| 2017-03-31 | 2017-05-02 | $18.29 million | -$0.33 | -$0.43 | 22.97% |
| 2016-12-31 | 2017-03-03 | $23.04 million | -$0.31 | -$0.51 | 39.18% |
| 2016-09-30 | 2016-11-01 | $27.72 million | -$0.35 | -$0.51 | 31.45% |
| 2016-06-30 | 2016-08-04 | $20.09 million | -$0.37 | -$0.41 | 9.36% |
| 2016-03-31 | 2016-05-03 | $12.49 million | -$0.34 | -$0.30 | -14.48% |
| 2015-12-31 | 2016-03-01 | $127.28 million | $0.76 | -$0.40 | 288.31% |
| 2015-09-30 | 2015-11-06 | $566000 | -$0.34 | -$0.36 | 5.56% |
| 2015-06-30 | 2015-08-07 | $376000 | -$0.27 | -$0.32 | 15.63% |
| 2015-03-31 | 2015-04-29 | $1.79 million | -$0.28 | -$0.29 | 3.45% |
| 2014-12-31 | 2015-03-04 | $21.48 million | -$0.03 | -$0.21 | 83.52% |
| 2014-09-30 | 2014-11-04 | $419000 | -$0.56 | -$0.35 | -60% |
| 2014-06-30 | 2014-08-07 | $676000 | -$0.35 | -$0.35 | 0% |
| 2014-03-31 | 2014-05-08 | $277000 | -$0.42 | -$0.34 | -23.53% |
| 2013-12-31 | 2014-02-28 | $1.41 million | -$0.21 | -$0.38 | 44.74% |
| 2013-09-30 | 2013-11-12 | $238000 | -$0.42 | -$0.10 | -320% |
| 2013-06-30 | 2013-07-30 | $214000 | -$0.42 | -$0.37 | -13.51% |
| 2013-03-31 | 2013-05-10 | $360000 | -$0.35 | -$0.35 | 0% |
| 2012-12-31 | 2013-02-21 | $218000 | -$0.35 | -$0.37 | 5.41% |
| 2012-09-30 | 2012-11-06 | $372000 | -$0.42 | -$0.41 | -2.44% |
| 2012-06-30 | 2012-07-31 | $199000 | -$0.35 | -$0.42 | 16.67% |
| 2012-03-31 | 2012-05-03 | $300000 | -$0.42 | -$0.49 | 14.29% |
| 2011-12-31 | 2012-02-22 | $343000 | -$0.70 | -$0.58 | -20.69% |
| 2011-09-30 | 2011-11-01 | $355000 | -$0.56 | -$0.61 | 8.2% |
| 2011-06-30 | 2011-08-08 | $555000 | -$0.56 | -$0.61 | 8.2% |
| 2011-03-31 | 2011-05-03 | $596000 | -$0.63 | -$0.49 | -28.57% |
| 2010-12-31 | 2011-02-24 | $1.25 million | -$0.49 | -$0.56 | 12.5% |
| 2010-09-30 | 2010-11-05 | $781000 | -$0.56 | -$0.56 | 0% |
| 2010-06-30 | 2010-08-09 | $1.23 million | -$0.49 | -$0.56 | 12.5% |
| 2010-03-31 | 2010-05-10 | $1.64 million | -$0.91 | -$0.49 | -85.71% |
| 2009-12-31 | 2010-02-23 | $1.41 million | -$0.91 | -$0.98 | 7.14% |
| 2009-09-30 | 2009-10-27 | $2.13 million | -$0.98 | ||
| 2009-06-30 | 2009-07-28 | $2.99 million | -$1.05 | -$1.12 | 6.25% |
| 2009-03-31 | 2009-04-28 | $4.17 million | -$1.12 | -$0.91 | -23.08% |
| 2008-12-31 | 2009-02-25 | $6.35 million | -$0.77 | -$1.19 | 35.29% |
| 2008-09-30 | 2008-10-30 | $7.51 million | -$1.19 | -$1.11 | -7.21% |
| 2008-06-30 | 2008-07-29 | $9.57 million | -$1.05 | -$1.08 | 2.78% |
| 2008-03-31 | 2008-04-29 | $8.89 million | -$0.91 | -$0.91 | 0% |
| 2007-12-31 | 2008-03-06 | $13.81 million | -$0.63 | -$0.87 | 27.59% |
| 2007-09-30 | 2007-10-30 | $10.17 million | -$0.98 | -$1.10 | 10.91% |
| 2007-06-30 | 2007-07-31 | $12.65 million | -$1.19 | -$1.54 | 22.73% |
| 2007-03-31 | 2007-05-01 | $13.5 million | -$1.68 | -$2.01 | 16.42% |
| 2006-12-31 | 2007-02-21 | $16.07 million | -$1.33 | -$1.66 | 19.88% |
| 2006-09-30 | 2006-10-31 | $19.61 million | -$1.40 | -$1.71 | 18.13% |
| 2006-06-30 | 2006-08-01 | $16.16 million | -$1.82 | -$1.94 | 6.19% |
| 2006-03-31 | 2006-05-02 | $20.96 million | -$1.19 | -$1.35 | 11.85% |
| 2005-12-31 | 2006-02-22 | $33.89 million | $0.63 | $0.26 | 142.31% |
| 2005-09-30 | 2005-11-01 | $13.96 million | -$1.54 | -$1.82 | 15.38% |
| 2005-06-30 | 2005-07-28 | $13.9 million | -$1.61 | -$2.04 | 21.08% |
| 2005-03-31 | 2005-04-28 | $13.93 million | -$1.47 | -$1.87 | 21.39% |
| 2004-12-31 | 2005-02-24 | $26.01 million | -$0.07 | -$0.78 | 91.03% |
| 2004-09-30 | 2004-10-28 | $13.11 million | -$1.61 | -$1.74 | 7.47% |
| 2004-06-30 | 2004-07-29 | $10.78 million | -$1.82 | -$1.96 | 7.14% |
| 2004-03-31 | 2004-04-29 | $11.84 million | -$1.75 | -$1.78 | 1.69% |
| 2003-12-31 | 2004-02-19 | $13.7 million | -$1.33 | -$1.43 | 6.99% |
| 2003-09-30 | 2003-10-30 | $12.11 million | -$1.40 | -$1.82 | 23.08% |
| 2003-06-30 | 2003-07-31 | $8.92 million | -$2.03 | -$2.13 | 4.69% |
| 2003-03-31 | 2003-05-01 | $8.11 million | -$1.96 | -$2.12 | 7.55% |
| 2002-12-31 | 2003-02-19 | $10.12 million | -$1.54 | -$2.03 | 24.14% |
| 2002-09-30 | 2002-10-30 | $8.01 million | -$1.89 | -$1.80 | -5% |
| 2002-06-30 | 2002-08-07 | $9.41 million | -$1.68 | -$1.77 | 5.08% |
| 2002-03-31 | 2002-05-09 | $7.66 million | -$1.54 | -$1.98 | 22.22% |
| 2001-12-31 | 2002-03-07 | $10.27 million | -$1.12 | -$1.26 | 11.11% |
| 2001-09-30 | 2001-11-06 | $13.49 million | -$0.49 | -$0.94 | 47.87% |
| 2001-06-30 | 2001-08-07 | $3.5 million | -$1.40 | -$1.01 | -38.61% |
| 2001-03-31 | 2001-05-08 | $3.31 million | -$0.77 | -$1.05 | 26.67% |
| 2000-12-31 | 2001-03-07 | $2.92 million | -$0.77 | -$0.87 | 11.49% |
| 2000-09-30 | 2000-10-26 | $5.61 million | -$0.21 | -$0.70 | 70% |
| 2000-06-30 | 2000-07-27 | $2.58 million | -$0.56 | -$0.44 | -27.27% |
Lexicon Pharmaceuticals, Inc (LXRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Lexicon Pharmaceuticals, Inc (LXRX) Chart:
Lexicon Pharmaceuticals, Inc (LXRX) News:
Below you will find a list of latest news for Lexicon Pharmaceuticals, Inc (LXRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Lexicon Pharmaceuticals, Inc (LXRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 0.5 | 0 | CALL | 0 | 0 | 249.44 | TRUE | 0 | 0 |
| 2025-01-17 | 1 | 0.65 | CALL | 0 | 1262 | 166.84 | TRUE | 0 | 0 |
| 2025-01-17 | 1.5 | 0.45 | CALL | 0 | 1899 | 122.05 | TRUE | 0 | 0 |
| 2025-01-17 | 2 | 0.25 | CALL | 0 | 3760 | 117.62 | FALSE | 0 | 0 |
| 2025-01-17 | 2.5 | 0.05 | CALL | 15 | 1922 | 72.57 | FALSE | -0.1 | -0.67 |
| 2025-01-17 | 5 | 0.1 | CALL | 0 | 545 | 159.17 | FALSE | 0 | 0 |
| 2025-01-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 1.5 | 0.3 | PUT | 2 | 458 | 105.8 | FALSE | 0.3 | 0 |
| 2025-01-17 | 2 | 0.65 | PUT | 0 | 565 | 103.94 | TRUE | 0 | 0 |
| 2025-01-17 | 2.5 | 1.09 | PUT | 0 | 196 | 127.01 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 0 | PUT | 0 | 0 | 204.73 | TRUE | 0 | 0 |
| 2025-01-17 | 7.5 | 0 | PUT | 0 | 0 | 206.8 | TRUE | 0 | 0 |
| 2025-04-17 | 0.5 | 0 | CALL | 0 | 0 | 182.28 | TRUE | 0 | 0 |
| 2025-04-17 | 1 | 0.78 | CALL | 0 | 6 | 85.25 | TRUE | 0 | 0 |
| 2025-04-17 | 1.5 | 0.55 | CALL | 0 | 124 | 82.82 | TRUE | 0 | 0 |
| 2025-04-17 | 2 | 0.35 | CALL | 0 | 185 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0.33 | CALL | 0 | 33 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 2 | 0 | PUT | 0 | 0 | 106.17 | TRUE | 0 | 0 |
| 2025-04-17 | 2.5 | 0 | PUT | 0 | 0 | 113.53 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0 | PUT | 0 | 0 | 130.28 | TRUE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 142.6 | TRUE | 0 | 0 |
| 2026-01-16 | 0.5 | 0 | CALL | 0 | 0 | 114.44 | TRUE | 0 | 0 |
| 2026-01-16 | 1 | 0.85 | CALL | 0 | 4 | 110.4 | TRUE | 0 | 0 |
| 2026-01-16 | 1.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 2 | 0.43 | CALL | 0 | 1 | 119.99 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 2 | 0 | PUT | 0 | 0 | 117.52 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | PUT | 0 | 0 | 82.04 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 0 | PUT | 0 | 0 | 102.77 | TRUE | 0 | 0 |
| 2027-01-15 | 0.5 | 1.35 | CALL | 0 | 26 | 138.19 | TRUE | 0 | 0 |
| 2027-01-15 | 1 | 0 | CALL | 0 | 0 | 119.94 | TRUE | 0 | 0 |
| 2027-01-15 | 1.5 | 0.9 | CALL | 0 | 1 | 101.19 | TRUE | 0 | 0 |
| 2027-01-15 | 2 | 0 | CALL | 0 | 0 | 98.07 | FALSE | 0 | 0 |
| 2027-01-15 | 2.5 | 0.67 | CALL | 0 | 30 | 101.88 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2027-01-15 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2027-01-15 | 1 | 0 | PUT | 0 | 0 | 168.95 | FALSE | 0 | 0 |
| 2027-01-15 | 1.5 | 0.55 | PUT | 0 | 10 | 164.93 | FALSE | 0 | 0 |
| 2027-01-15 | 2 | 0 | PUT | 0 | 0 | 150.18 | TRUE | 0 | 0 |
| 2027-01-15 | 2.5 | 0 | PUT | 0 | 0 | 145.57 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 0 | PUT | 0 | 0 | 135.57 | TRUE | 0 | 0 |
Latest LXRX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:58 PM EST | 55 | $1.425 |
| Jun 13, 2022 7:59 PM EST | 110 | $1.425 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.425 |
| Jun 13, 2022 7:59 PM EST | 55 | $1.425 |
| Jun 13, 2022 7:59 PM EST | 90 | $1.425 |
Lexicon Pharmaceuticals, Inc (LXRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000030/0001062822-20-000030-index.htm |
| 2019-11-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1062822/000000000019015489/0000000000-19-015489-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1062822/000031506619001193/0000315066-19-001193-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1062822/000031506620001065/0000315066-20-001065-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1062822/000086117719000007/0000861177-19-000007-index.htm |
| 2018-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014494/0000899243-18-014494-index.htm |
| 2018-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014948/0000899243-18-014948-index.htm |
| 2018-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318015606/0000899243-18-015606-index.htm |
| 2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318016245/0000899243-18-016245-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017071/0000899243-18-017071-index.htm |
| 2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017617/0000899243-18-017617-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318018161/0000899243-18-018161-index.htm |
| 2018-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000089924318018727/0000899243-18-018727-index.htm |
| 2018-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000020/0001062822-18-000020-index.htm |
| 2018-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000022/0001062822-18-000022-index.htm |
| 2018-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000025/0001062822-18-000025-index.htm |
| 2018-07-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000026/0001062822-18-000026-index.htm |
| 2018-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000030/0001062822-18-000030-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000035/0001062822-18-000035-index.htm |
| 2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282218000036/0001062822-18-000036-index.htm |
| 2019-02-15 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000002/0001062822-19-000002-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000005/0001062822-19-000005-index.htm |
| 2019-03-15 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000007/0001062822-19-000007-index.htm |
| 2019-03-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000008/0001062822-19-000008-index.htm |
| 2019-03-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000010/0001062822-19-000010-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000012/0001062822-19-000012-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000015/0001062822-19-000015-index.htm |
| 2019-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000017/0001062822-19-000017-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000020/0001062822-19-000020-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000022/0001062822-19-000022-index.htm |
| 2019-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000024/0001062822-19-000024-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000026/0001062822-19-000026-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000028/0001062822-19-000028-index.htm |
| 2019-11-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000030/0001062822-19-000030-index.htm |
| 2019-11-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000032/0001062822-19-000032-index.htm |
| 2019-11-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1062822/000106282219000034/0001062822-19-000034-index.htm |
| 2020-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000002/0001062822-20-000002-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000012/0001062822-20-000012-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000015/0001062822-20-000015-index.htm |
| 2020-03-13 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000016/0001062822-20-000016-index.htm |
| 2020-03-13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000017/0001062822-20-000017-index.htm |
| 2020-04-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000019/0001062822-20-000019-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000022/0001062822-20-000022-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000025/0001062822-20-000025-index.htm |
| 2020-04-27 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000027/0001062822-20-000027-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000030/0001062822-20-000030-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000033/0001062822-20-000033-index.htm |
| 2020-07-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000040/0001062822-20-000040-index.htm |
| 2020-07-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000041/0001062822-20-000041-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000043/0001062822-20-000043-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000045/0001062822-20-000045-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000047/0001062822-20-000047-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000049/0001062822-20-000049-index.htm |
| 2020-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000053/0001062822-20-000053-index.htm |
| 2020-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000056/0001062822-20-000056-index.htm |
| 2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000058/0001062822-20-000058-index.htm |
| 2020-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000060/0001062822-20-000060-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000063/0001062822-20-000063-index.htm |
| 2020-10-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000067/0001062822-20-000067-index.htm |
| 2020-10-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1062822/000106282220000069/0001062822-20-000069-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015439/0001127602-18-015439-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015441/0001127602-18-015441-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015443/0001127602-18-015443-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015446/0001127602-18-015446-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015449/0001127602-18-015449-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015451/0001127602-18-015451-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015454/0001127602-18-015454-index.htm |
| 2018-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015457/0001127602-18-015457-index.htm |
| 2018-05-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218018984/0001127602-18-018984-index.htm |
| 2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760218020694/0001127602-18-020694-index.htm |
| 2019-02-08 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004861/0001127602-19-004861-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004868/0001127602-19-004868-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004874/0001127602-19-004874-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004879/0001127602-19-004879-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004882/0001127602-19-004882-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004888/0001127602-19-004888-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004890/0001127602-19-004890-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219004892/0001127602-19-004892-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009259/0001127602-19-009259-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/0001127602-19-009261-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009262/0001127602-19-009262-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009264/0001127602-19-009264-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009266/0001127602-19-009266-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/0001127602-19-009267-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009268/0001127602-19-009268-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016487/0001127602-19-016487-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016490/0001127602-19-016490-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016491/0001127602-19-016491-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016492/0001127602-19-016492-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016493/0001127602-19-016493-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016495/0001127602-19-016495-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016496/0001127602-19-016496-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219016497/0001127602-19-016497-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219025862/0001127602-19-025862-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219025869/0001127602-19-025869-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028744/0001127602-19-028744-index.htm |
| 2019-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028812/0001127602-19-028812-index.htm |
| 2019-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028814/0001127602-19-028814-index.htm |
| 2019-11-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760219031730/0001127602-19-031730-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004589/0001127602-20-004589-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004591/0001127602-20-004591-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004595/0001127602-20-004595-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004597/0001127602-20-004597-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004599/0001127602-20-004599-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004602/0001127602-20-004602-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004603/0001127602-20-004603-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220004609/0001127602-20-004609-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008948/0001127602-20-008948-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008951/0001127602-20-008951-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008956/0001127602-20-008956-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/0001127602-20-008962-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008965/0001127602-20-008965-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008967/0001127602-20-008967-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/0001127602-20-008968-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008971/0001127602-20-008971-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014487/0001127602-20-014487-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014489/0001127602-20-014489-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014491/0001127602-20-014491-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014492/0001127602-20-014492-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014493/0001127602-20-014493-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014494/0001127602-20-014494-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014495/0001127602-20-014495-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014560/0001127602-20-014560-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014562/0001127602-20-014562-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014563/0001127602-20-014563-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014565/0001127602-20-014565-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014566/0001127602-20-014566-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014568/0001127602-20-014568-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014570/0001127602-20-014570-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014572/0001127602-20-014572-index.htm |
| 2018-06-04 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1062822/000119312518182450/0001193125-18-182450-index.htm |
| 2018-06-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1062822/000119312518209658/0001193125-18-209658-index.htm |
| 2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1062822/000119312519204244/0001193125-19-204244-index.htm |
| 2019-11-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1062822/999999999519002603/9999999995-19-002603-index.htm |
| 2019-04-29 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1062822/999999999719003595/9999999997-19-003595-index.htm |
Lexicon Pharmaceuticals, Inc (LXRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lexicon Pharmaceuticals, Inc (LXRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 90%Institutional Ownership: 9196%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 15,158.00 | 2.44 | 36,985.52 | 100,857.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-02-28 | Alexander A Santini | EVP and CCO | Buy | 2,593.00 | 10,242.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009264/0001127602-19-009264-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 2,400.00 | 2.45 | 5,880.00 | 103,257.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2020-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 22,373.00 | 104,319.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008956/0001127602-20-008956-index.htm | ||
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 6,600.00 | 1.34 | 8,844.00 | 104,439.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 600.00 | 1.35 | 807.00 | 105,039.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2019-02-28 | LONNEL COATS | President and CEO | Buy | 23,513.00 | 106,180.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009259/0001127602-19-009259-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 5,200.00 | 2.46 | 12,792.00 | 108,457.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 3,500.00 | 1.35 | 4,725.00 | 108,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 100.00 | 2.47 | 246.50 | 108,557.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2020-04-22 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 19,893.00 | 111,453.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014491/0001127602-20-014491-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 3,336.00 | 2.47 | 8,239.92 | 111,893.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 100.00 | 2.48 | 247.75 | 111,993.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 300.00 | 2.48 | 744.00 | 112,293.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 200.00 | 2.38 | 476.00 | 112,493.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 800.00 | 2.40 | 1,920.00 | 113,293.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 300.00 | 2.41 | 723.00 | 113,593.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 500.00 | 2.43 | 1,215.00 | 114,093.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 295.00 | 2.52 | 741.93 | 114,388.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2020-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 25,290.00 | 114,646.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008971/0001127602-20-008971-index.htm | ||
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 776.00 | 2.51 | 1,947.76 | 115,164.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 100.00 | 2.49 | 248.50 | 115,264.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 34,087.00 | 2.40 | 81,808.80 | 115,290.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 1,784.00 | 2.49 | 4,442.16 | 117,048.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 1,400.00 | 2.46 | 3,444.00 | 118,448.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 200.00 | 2.45 | 490.00 | 118,648.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 2,500.00 | 2.47 | 6,175.00 | 121,148.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 3,300.00 | 2.48 | 8,184.00 | 124,448.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 16,000.00 | 1.36 | 21,760.00 | 124,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2020-04-22 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 26,525.00 | 125,146.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014495/0001127602-20-014495-index.htm | ||
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 1,151.00 | 2.50 | 2,877.50 | 125,599.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 100.00 | 2.54 | 253.50 | 125,699.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 100.00 | 2.53 | 252.50 | 125,799.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 1,405.00 | 2.52 | 3,540.60 | 127,204.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-08-19 | LONNEL COATS | President and CEO | Buy | 3,000.00 | 1.40 | 4,194.00 | 127,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2019-09-17 | LONNEL COATS | President and CEO | Buy | 100.00 | 3.13 | 312.50 | 127,639.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028744/0001127602-19-028744-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 820.00 | 2.53 | 2,074.60 | 128,024.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 400.00 | 2.55 | 1,020.00 | 128,424.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2018-04-27 | Frank Palantoni | Director | Buy | 2,564.00 | 12,902.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015451/0001127602-18-015451-index.htm | ||
| 2018-04-27 | Judith L Swain | Director | Buy | 2,564.00 | 12,902.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015457/0001127602-18-015457-index.htm | ||
| 2018-04-27 | Philippe Amouyal | Director | Buy | 2,564.00 | 12,902.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015439/0001127602-18-015439-index.htm | ||
| 2018-04-27 | RAYMOND DEBBANE | Director | Buy | 2,564.00 | 12,902.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015443/0001127602-18-015443-index.htm | ||
| 2018-04-27 | ROBERT J MD LEFKOWITZ | Director | Buy | 2,564.00 | 12,902.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015446/0001127602-18-015446-index.htm | ||
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 800.00 | 2.54 | 2,032.00 | 129,224.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 900.00 | 2.56 | 2,304.00 | 130,124.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 100.00 | 2.58 | 258.00 | 130,224.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2018-04-27 | CHRISTOPHER J SOBECKI | Director | Buy | 2,564.00 | 13,044.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015454/0001127602-18-015454-index.htm | ||
| 2019-09-17 | LONNEL COATS | President and CEO | Buy | 3,000.00 | 3.12 | 9,357.00 | 130,639.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028744/0001127602-19-028744-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 200.00 | 2.25 | 450.00 | 13,102.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 900.00 | 2.57 | 2,313.00 | 131,124.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 200.00 | 2.59 | 518.00 | 131,324.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 791.00 | 2.60 | 2,056.60 | 132,115.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 400.00 | 2.27 | 908.00 | 13,502.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 3,700.00 | 2.75 | 10,175.00 | 135,815.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2018-04-27 | ALAN S NIES | Director | Buy | 2,564.00 | 13,616.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015449/0001127602-18-015449-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 601.00 | 2.25 | 1,352.25 | 13,645.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-17 | LONNEL COATS | President and CEO | Buy | 6,333.00 | 3.12 | 19,758.96 | 136,972.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028744/0001127602-19-028744-index.htm |
| 2019-09-17 | LONNEL COATS | President and CEO | Buy | 277.00 | 3.13 | 866.90 | 137,249.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028744/0001127602-19-028744-index.htm |
| 2019-09-16 | CHRISTOPHER J SOBECKI | Director | Buy | 1,478.00 | 2.73 | 4,034.94 | 137,293.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/0001127602-19-028593-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 300.00 | 2.28 | 684.00 | 13,802.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 200.00 | 2.27 | 454.00 | 13,845.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 24,772.00 | 2.41 | 59,700.52 | 140,062.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 200.00 | 2.42 | 483.00 | 140,262.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2020-04-26 | CHRISTOPHER J SOBECKI | Director | Buy | 3,466.00 | 140,759.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014570/0001127602-20-014570-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 300.00 | 2.29 | 687.00 | 14,102.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 500.00 | 2.28 | 1,140.00 | 14,345.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 400.00 | 2.30 | 920.00 | 14,745.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 800.00 | 2.30 | 1,840.00 | 14,902.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-02-28 | PRAVEEN TYLE | EVP, R&D | Buy | 9,727.00 | 14,979.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/0001127602-19-009267-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 500.00 | 2.31 | 1,155.00 | 15,402.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 15,582.00 | 2.42 | 37,708.44 | 155,844.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 900.00 | 2.43 | 2,182.50 | 156,744.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 1,600.00 | 2.31 | 3,696.00 | 16,345.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2020-04-26 | Frank Palantoni | Director | Buy | 3,466.00 | 16,368.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014568/0001127602-20-014568-index.htm | ||
| 2020-04-26 | Judith L Swain | Director | Buy | 3,466.00 | 16,368.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014572/0001127602-20-014572-index.htm | ||
| 2020-04-26 | Philippe Amouyal | Director | Buy | 3,466.00 | 16,368.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014560/0001127602-20-014560-index.htm | ||
| 2020-04-26 | ROBERT J MD LEFKOWITZ | Director | Buy | 3,466.00 | 16,368.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014565/0001127602-20-014565-index.htm | ||
| 2019-09-18 | Alexander A Santini | EVP and CCO | Buy | 2,500.00 | 3.23 | 8,075.00 | 16,661.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028812/0001127602-19-028812-index.htm |
| 2018-05-25 | Invus Public Equities, L.P. | Director | Buy | 138,700.00 | 9.62 | 1,334,973.63 | 1,688,700.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014494/0000899243-18-014494-index.htm |
| 2020-04-26 | ALAN S NIES | Director | Buy | 3,466.00 | 17,082.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014566/0001127602-20-014566-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 1,000.00 | 2.32 | 2,320.00 | 17,345.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 18,051.00 | 2.43 | 43,863.93 | 174,795.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 1,700.00 | 2.44 | 4,139.50 | 176,495.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 2,309.00 | 2.32 | 5,356.88 | 17,711.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-17 | LONNEL COATS | President and CEO | Buy | 40,290.00 | 3.13 | 126,107.70 | 177,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028744/0001127602-19-028744-index.htm |
| 2020-02-28 | PRAVEEN TYLE | EVP, R&D | Buy | 2,990.00 | 17,969.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/0001127602-20-008968-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 1,000.00 | 2.33 | 2,330.00 | 18,345.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2018-05-29 | Invus Public Equities, L.P. | Director | Buy | 147,339.00 | 9.84 | 1,450,419.85 | 1,836,039.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014494/0000899243-18-014494-index.htm |
| 2019-09-18 | Alexander A Santini | EVP and CCO | Buy | 2,000.00 | 3.52 | 7,040.00 | 18,661.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028812/0001127602-19-028812-index.htm |
| 2019-02-28 | Alexander A Santini | EVP and CCO | Buy | 8,463.00 | 18,705.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009264/0001127602-19-009264-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 1,300.00 | 2.33 | 3,029.00 | 19,011.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2018-05-30 | Invus Public Equities, L.P. | Director | Buy | 147,339.00 | 10.32 | 1,521,024.70 | 1,983,378.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014494/0000899243-18-014494-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 1,101.00 | 2.34 | 2,576.34 | 20,112.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 29,880.00 | 2.44 | 72,907.20 | 206,375.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 100.00 | 2.45 | 244.50 | 206,475.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2020-02-28 | Alexander A Santini | EVP and CCO | Buy | 2,353.00 | 21,014.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008965/0001127602-20-008965-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 3,800.00 | 2.45 | 9,310.00 | 210,275.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 100.00 | 2.46 | 245.50 | 210,375.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2018-05-31 | Invus Public Equities, L.P. | Director | Buy | 147,339.00 | 11.62 | 1,712,049.71 | 2,130,717.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014948/0000899243-18-014948-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 1,700.00 | 2.35 | 3,995.00 | 21,812.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 3,500.00 | 2.34 | 8,190.00 | 21,845.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 8,869.00 | 2.46 | 21,817.74 | 219,244.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 400.00 | 2.47 | 988.00 | 219,644.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 200.00 | 2.36 | 471.00 | 22,012.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 3,990.00 | 2.60 | 10,374.00 | 223,634.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 600.00 | 2.35 | 1,410.00 | 22,445.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-18 | LONNEL COATS | President and CEO | Buy | 50,000.00 | 3.10 | 155,000.00 | 227,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028814/0001127602-19-028814-index.htm |
| 2018-06-01 | Invus Public Equities, L.P. | Director | Buy | 147,339.00 | 12.22 | 1,800,040.56 | 2,278,056.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014948/0000899243-18-014948-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 5,795.00 | 2.61 | 15,124.95 | 229,429.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 3,110.00 | 2.62 | 8,148.20 | 232,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2020-02-28 | LONNEL COATS | President and CEO | Buy | 8,390.00 | 235,929.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008948/0001127602-20-008948-index.htm | ||
| 2020-02-28 | Alexander A Santini | EVP and CCO | Buy | 2,593.00 | 23,607.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008965/0001127602-20-008965-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 1,200.00 | 2.36 | 2,832.00 | 23,645.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 4,800.00 | 2.63 | 12,624.00 | 237,339.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 2,100.00 | 2.64 | 5,544.00 | 239,439.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2018-06-04 | Invus Public Equities, L.P. | Director | Buy | 121,803.00 | 12.24 | 1,490,576.39 | 2,399,859.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318014948/0000899243-18-014948-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 1,100.00 | 2.66 | 2,926.00 | 240,539.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 2,068.00 | 2.36 | 4,880.48 | 24,080.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2020-02-28 | LONNEL COATS | President and CEO | Buy | 5,363.00 | 241,292.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008948/0001127602-20-008948-index.htm | ||
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 4,600.00 | 2.67 | 12,282.00 | 245,139.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 1,300.00 | 2.68 | 3,484.00 | 246,439.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 500.00 | 2.69 | 1,345.00 | 246,939.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 400.00 | 2.70 | 1,080.00 | 247,339.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 6,443.00 | 2.71 | 17,460.53 | 253,782.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2020-02-28 | Brian T Crum | VP, General Counsel & Secr. | Buy | 2,515.00 | 25,440.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008951/0001127602-20-008951-index.htm | ||
| 2018-06-08 | James F Tessmer | VP, Finance & Accounting | Sell | 10,000.00 | 12.91 | 129,076.00 | 25,643.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218020694/0001127602-18-020694-index.htm |
| 2018-06-05 | Invus Public Equities, L.P. | Director | Buy | 173,121.00 | 12.45 | 2,156,187.43 | 2,572,980.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318015606/0000899243-18-015606-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 2,206.00 | 2.37 | 5,228.22 | 25,851.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 8,082.00 | 2.72 | 21,983.04 | 261,864.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2020-02-28 | LONNEL COATS | President and CEO | Buy | 23,514.00 | 264,806.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008948/0001127602-20-008948-index.htm | ||
| 2018-06-06 | Invus Public Equities, L.P. | Director | Buy | 95,079.00 | 12.58 | 1,196,369.55 | 2,668,059.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318015606/0000899243-18-015606-index.htm |
| 2020-02-28 | Brian T Crum | VP, General Counsel & Secr. | Buy | 1,518.00 | 26,958.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008951/0001127602-20-008951-index.htm | ||
| 2018-06-07 | Invus Public Equities, L.P. | Director | Buy | 57,439.00 | 12.93 | 742,508.21 | 2,725,498.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318015606/0000899243-18-015606-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 11,100.00 | 2.73 | 30,303.00 | 272,964.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 1,900.00 | 2.74 | 5,206.00 | 274,864.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2018-06-08 | Invus Public Equities, L.P. | Director | Buy | 29,747.00 | 12.89 | 383,426.93 | 2,755,245.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318016245/0000899243-18-016245-index.htm |
| 2020-02-28 | PRAVEEN TYLE | EVP, R&D | Buy | 9,726.00 | 27,695.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/0001127602-20-008968-index.htm | ||
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 6,853.00 | 2.75 | 18,845.75 | 281,717.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2018-04-27 | SAM L BARKER | Director | Buy | 2,564.00 | 28,187.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218015441/0001127602-18-015441-index.htm | ||
| 2019-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 2,668.00 | 28,311.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009266/0001127602-19-009266-index.htm | ||
| 2018-06-11 | Invus Public Equities, L.P. | Director | Buy | 98,626.00 | 12.75 | 1,257,451.91 | 2,853,871.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318016245/0000899243-18-016245-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 4,500.00 | 2.76 | 12,420.00 | 286,217.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 5,494.00 | 2.37 | 13,020.78 | 29,574.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2018-06-12 | Invus Public Equities, L.P. | Director | Buy | 107,023.00 | 12.83 | 1,373,244.22 | 2,960,894.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318016245/0000899243-18-016245-index.htm |
| 2018-06-14 | Invus Public Equities, L.P. | Director | Buy | 9,200.00 | 12.66 | 116,461.88 | 2,970,094.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017071/0000899243-18-017071-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 12,400.00 | 2.77 | 34,348.00 | 298,617.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 400.00 | 2.38 | 950.00 | 29,974.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2018-06-18 | Invus Public Equities, L.P. | Director | Buy | 36,584.00 | 13.06 | 477,937.03 | 3,006,678.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017071/0000899243-18-017071-index.htm |
| 2018-06-19 | Invus Public Equities, L.P. | Director | Buy | 8,982.00 | 13.45 | 120,818.68 | 3,015,660.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017617/0000899243-18-017617-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 3,900.00 | 2.78 | 10,842.00 | 302,517.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2018-06-20 | Invus Public Equities, L.P. | Director | Buy | 12,391.00 | 13.28 | 164,613.20 | 3,028,051.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017617/0000899243-18-017617-index.htm |
| 2019-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 2,075.00 | 30,386.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009266/0001127602-19-009266-index.htm | ||
| 2018-06-21 | Invus Public Equities, L.P. | Director | Buy | 51,600.00 | 13.27 | 684,613.32 | 3,079,651.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318017617/0000899243-18-017617-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 7,500.00 | 2.79 | 20,925.00 | 310,017.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2018-06-22 | Invus Public Equities, L.P. | Director | Buy | 25,461.00 | 13.36 | 340,090.22 | 3,105,112.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318018161/0000899243-18-018161-index.htm |
| 2019-09-16 | RAYMOND DEBBANE | Director | Buy | 3,400.00 | 2.80 | 9,520.00 | 313,417.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028597/0001127602-19-028597-index.htm |
| 2019-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 1,270.00 | 31,656.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009266/0001127602-19-009266-index.htm | ||
| 2020-04-26 | RAYMOND DEBBANE | Director | Buy | 3,466.00 | 316,883.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014563/0001127602-20-014563-index.htm | ||
| 2020-02-28 | Alexander A Santini | EVP and CCO | Buy | 8,464.00 | 32,071.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008965/0001127602-20-008965-index.htm | ||
| 2020-02-28 | Brian T Crum | VP, General Counsel & Secr. | Buy | 5,119.00 | 32,077.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008951/0001127602-20-008951-index.htm | ||
| 2018-06-25 | Invus Public Equities, L.P. | Director | Buy | 228,264.00 | 12.95 | 2,955,082.92 | 3,333,376.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318018161/0000899243-18-018161-index.htm |
| 2020-02-28 | LONNEL COATS | President and CEO | Buy | 79,380.00 | 344,186.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008948/0001127602-20-008948-index.htm | ||
| 2018-06-27 | Invus Public Equities, L.P. | Director | Buy | 125,114.00 | 12.54 | 1,568,441.62 | 3,458,490.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318018727/0000899243-18-018727-index.htm |
| 2018-06-28 | Invus Public Equities, L.P. | Director | Buy | 57,724.00 | 12.45 | 718,935.10 | 3,516,214.00 | https://www.sec.gov/Archives/edgar/data/1062822/000089924318018727/0000899243-18-018727-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 9,784.00 | 2.38 | 23,285.92 | 35,635.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2018-06-08 | James F Tessmer | VP, Finance & Accounting | Buy | 10,000.00 | 10.15 | 101,500.00 | 35,643.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218020694/0001127602-18-020694-index.htm |
| 2019-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 4,213.00 | 35,869.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009266/0001127602-19-009266-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 1,396.00 | 2.39 | 3,329.46 | 37,031.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 4,550.00 | 38,525.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/0001127602-19-009261-index.htm | ||
| 2019-08-02 | SAM L BARKER | Director | Buy | 12,000.00 | 1.17 | 14,040.00 | 40,187.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219025862/0001127602-19-025862-index.htm |
| 2019-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 4,227.00 | 42,752.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/0001127602-19-009261-index.htm | ||
| 2020-02-28 | Brian T Crum | VP, General Counsel & Secr. | Buy | 11,100.00 | 43,177.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008951/0001127602-20-008951-index.htm | ||
| 2019-08-02 | James F Tessmer | VP, Finance & Accounting | Buy | 10,000.00 | 1.14 | 11,400.00 | 43,368.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219025869/0001127602-19-025869-index.htm |
| 2019-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 2,585.00 | 45,337.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/0001127602-19-009261-index.htm | ||
| 2020-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 2,075.00 | 45,443.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008967/0001127602-20-008967-index.htm | ||
| 2020-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 1,270.00 | 46,713.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008967/0001127602-20-008967-index.htm | ||
| 2020-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 4,214.00 | 50,927.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008967/0001127602-20-008967-index.htm | ||
| 2020-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 4,228.00 | 51,326.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/0001127602-20-008962-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 14,338.00 | 2.39 | 34,267.82 | 51,369.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-08-02 | SAM L BARKER | Director | Buy | 12,000.00 | 1.18 | 14,160.00 | 52,187.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219025862/0001127602-19-025862-index.htm |
| 2019-02-28 | PRAVEEN TYLE | EVP, R&D | Buy | 2,990.00 | 5,252.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009267/0001127602-19-009267-index.htm | ||
| 2018-05-23 | Alexander A Santini | EVP and CCO | Buy | 745.00 | 9.78 | 7,286.10 | 5,297.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760218018984/0001127602-18-018984-index.htm |
| 2019-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 8,570.00 | 53,907.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/0001127602-19-009261-index.htm | ||
| 2020-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 2,585.00 | 53,911.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/0001127602-20-008962-index.htm | ||
| 2020-02-28 | PRAVEEN TYLE | EVP, R&D | Buy | 26,600.00 | 54,295.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008968/0001127602-20-008968-index.htm | ||
| 2020-02-28 | Alexander A Santini | EVP and CCO | Buy | 22,853.00 | 54,924.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008965/0001127602-20-008965-index.htm | ||
| 2020-04-26 | SAM L BARKER | Director | Buy | 3,466.00 | 55,653.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014562/0001127602-20-014562-index.htm | ||
| 2020-04-22 | Brian T Crum | VP, General Counsel & Secr. | Buy | 19,893.00 | 56,130.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014489/0001127602-20-014489-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 28,225.00 | 2.38 | 67,175.50 | 58,199.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 5,271.00 | 59,072.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009262/0001127602-19-009262-index.htm | ||
| 2020-02-28 | James F Tessmer | VP, Finance & Accounting | Buy | 8,837.00 | 59,764.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008967/0001127602-20-008967-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 9,450.00 | 2.40 | 22,680.00 | 60,819.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 200.00 | 2.41 | 481.00 | 61,019.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2020-04-22 | Alexander A Santini | EVP and CCO | Buy | 19,893.00 | 62,397.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014492/0001127602-20-014492-index.htm | ||
| 2020-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 8,570.00 | 62,481.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/0001127602-20-008962-index.htm | ||
| 2019-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 4,085.00 | 63,157.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009262/0001127602-19-009262-index.htm | ||
| 2019-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 5,807.00 | 64,299.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009268/0001127602-19-009268-index.htm | ||
| 2019-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 2,498.00 | 65,655.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009262/0001127602-19-009262-index.htm | ||
| 2019-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 4,495.00 | 68,794.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009268/0001127602-19-009268-index.htm | ||
| 2019-02-28 | LONNEL COATS | President and CEO | Buy | 10,835.00 | 68,914.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009259/0001127602-19-009259-index.htm | ||
| 2020-04-22 | James F Tessmer | VP, Finance & Accounting | Buy | 13,262.00 | 69,124.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014493/0001127602-20-014493-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 8,112.00 | 2.41 | 19,549.92 | 69,131.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 1,000.00 | 2.42 | 2,415.00 | 70,131.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2020-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 4,085.00 | 71,152.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008956/0001127602-20-008956-index.htm | ||
| 2019-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 2,798.00 | 71,592.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009268/0001127602-19-009268-index.htm | ||
| 2020-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 2,498.00 | 73,650.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008956/0001127602-20-008956-index.htm | ||
| 2019-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 8,297.00 | 73,952.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009262/0001127602-19-009262-index.htm | ||
| 2020-04-22 | PRAVEEN TYLE | EVP, R&D | Buy | 19,893.00 | 74,188.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014494/0001127602-20-014494-index.htm | ||
| 2019-02-28 | Alexander A Santini | EVP and CCO | Buy | 2,352.00 | 7,649.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009264/0001127602-19-009264-index.htm | ||
| 2020-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 4,495.00 | 77,003.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008971/0001127602-20-008971-index.htm | ||
| 2019-02-28 | LONNEL COATS | President and CEO | Buy | 8,390.00 | 77,304.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009259/0001127602-19-009259-index.htm | ||
| 2020-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 2,798.00 | 79,801.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008971/0001127602-20-008971-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 21,652.00 | 2.39 | 51,748.28 | 79,851.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 9,943.00 | 2.42 | 24,062.06 | 80,074.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 1,200.00 | 2.40 | 2,874.00 | 81,051.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2019-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 9,555.00 | 81,147.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009268/0001127602-19-009268-index.htm | ||
| 2019-09-13 | RAYMOND DEBBANE | Director | Buy | 152.00 | 2.40 | 364.65 | 81,203.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028595/0001127602-19-028595-index.htm |
| 2020-02-28 | ALAN J MAIN | EVP, Commercial Supply Ops | Buy | 8,296.00 | 81,946.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008956/0001127602-20-008956-index.htm | ||
| 2019-02-28 | LONNEL COATS | President and CEO | Buy | 5,363.00 | 82,667.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219009259/0001127602-19-009259-index.htm | ||
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 5,225.00 | 2.43 | 12,696.75 | 85,299.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2019-09-13 | CHRISTOPHER J SOBECKI | Director | Buy | 400.00 | 2.44 | 974.00 | 85,699.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/0001127602-19-028591-index.htm |
| 2020-02-28 | Pablo Lapuerta | EVP and CMO | Buy | 23,463.00 | 85,944.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/0001127602-20-008962-index.htm | ||
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 156.00 | 1.33 | 206.70 | 87,695.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2020-02-28 | JEFFREY L WADE | EVP, Corp Adm Affairs and CFO | Buy | 9,555.00 | 89,356.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220008971/0001127602-20-008971-index.htm | ||
| 2020-04-22 | Pablo Lapuerta | EVP and CMO | Buy | 19,893.00 | 92,532.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760220014487/0001127602-20-014487-index.htm | ||
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 10,044.00 | 1.33 | 13,358.52 | 97,739.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |
| 2019-08-16 | LONNEL COATS | President and CEO | Buy | 100.00 | 1.34 | 133.50 | 97,839.00 | https://www.sec.gov/Archives/edgar/data/1062822/000112760219027072/0001127602-19-027072-index.htm |